Fiona Gaughran, FRCP | Psychiatrist.com

Oral Anticoagulants, Atrial Fibrillation, and Mental Illness

Original Research

Oral Anticoagulants, Atrial Fibrillation, and Mental Illness

January 3, 2024

People with atrial fibrillation (AF) and comorbid mental illness are less often prescribed an oral anticoagulant (OAC) for AF-related stroke prevention. This study examined how mental illness interacts with...

Dina Farran, Matthew Broadbent, Aikaterini Dima, et al

Original Research

Management of Treatment-Resistant Psychosis

September 24, 2019

Clozapine is the only medication approved for refractory schizophrenia, yet it is underused. Further, for minimal response to clozapine treatment, there is little guidance on the next step. Here,...

Amir Krivoy, Dan Joyce, Derek Tracy, et al

Original Research

Optimizing Outcomes in Clozapine Rechallenge Following Neutropenia: A Cohort Analysis

November 25, 2015

Nicholas Meyer, Siobhan Gee, Eromona Whiskey, et al